Observational Cohort of Pancreatic Echo-endoscopy
Ключови думи
Резюме
Описание
Little is known about the pathogenesis of the fatty pancreas. Fat can replace acinar cells and / or pancreatic endocrine cells (1). To date, there are no biomarkers allowing the detection of a fatty pancreas. It appears that older age, male, obesity, alcohol consumption, high triglycerides, high ALT, diabetes or insulin resistance, fatty liver and metabolic syndrome are risk factors for a fatty pancreas (2,3,4).To the investigator's knowledge, these different factors have not been evaluated on the impact of pancreatic echogenecity in endosonography. The objective of this study is to correlate the factors making up the metabolic syndrome with pancreatic echogenecity.
Дати
| Последна проверка: | 12/31/2019 |
| Първо изпратено: | 01/08/2020 |
| Очаквано записване подадено: | 01/09/2020 |
| Първо публикувано: | 01/12/2020 |
| Изпратена последна актуализация: | 01/09/2020 |
| Последна актуализация публикувана: | 01/12/2020 |
| Действителна начална дата на проучването: | 07/16/2018 |
| Приблизителна дата на първично завършване: | 04/15/2019 |
| Очаквана дата на завършване на проучването: | 09/14/2019 |
Състояние или заболяване
Интервенция / лечение
Procedure: Patients with echo-endoscopic ultrasound of the pancreas
Фаза
Групи за ръце
| Arm | Интервенция / лечение |
|---|---|
| Patients with echo-endoscopic ultrasound of the pancreas Patients requiring endoscopic ultrasound of the pancreas were included in the cohort. | Procedure: Patients with echo-endoscopic ultrasound of the pancreas Echo-endoscopy ultrasound is an examination that presents little risk. However, any medical act, exploration, intervention even conducted under conditions of competence and safety in accordance with current data of medicine and the regulations in force, conceals a risk of complications. In particular, esophageal perforations can occur. They are often favored by underlying lesions (tumor, diverticulum, anatomical variants ...). Other complications are possible such as cardiovascular, respiratory or infectious disorders, as with any anesthesia. |
Критерии за допустимост
| Възрасти, отговарящи на условията за проучване | 18 Years Да се 18 Years |
| Полове, допустими за проучване | All |
| Метод за вземане на проби | Non-Probability Sample |
| Приема здрави доброволци | Да |
| Критерии | Inclusion Criteria: - any consecutive patient, having a high echo-endoscopy - for an extra pancreatic cause, such as the search for a cholelithiasis, (the pancreas will be studied completely) - for esophageal pathologies, (the pancreas will be studied completely) - for gastric pathologies, (the pancreas will be studied completely) - for cystic lesions of the pancreas (pancreas studied upstream and downstream) - for submucosal tumors (esophageal / gastric / duodenal) - for abdominal pain of undetermined origin Exclusion Criteria: - Patients with pancreatic and / or tissue damage with dilated wirsung canal and / or acute or chronic pancreatitis. - Patients having contraindication to general anesthesia |
Резултат
Първични изходни мерки
1. Correlation of the pancreatic echogenicity by endoscopic ultrasound with the metabolic syndrome [During the reading of the echo-endoscopic procedure]
Вторични изходни мерки
1. Comparaison of the echogenicity of the pancreas with respect to the liver and to the spleen will be made. [During the reading of the echo-endoscopic procedure]
